Jones Day

Anthony M. Insogna

Current View:

This content is provided by Anthony M. Insogna.


Anthony leads Jones Day's IP Practice comprising approximately 235 IP professionals located throughout the U.S., Europe, Asia and Australia. With over 25 years of life sciences experience, Anthony has created, enforced and defended patent portfolios for dozens of FDA approved products invented or developed by emerging companies as well as by the world’s leading pharmaceutical and biotech companies. Anthony has significant experience in enforcing patents for branded drug companies in Hatch-Waxman litigation. He has defended patents for the world’s biggest selling products including PTAB matters for Humira®, and global litigation against Revlimid®.